Advanced Dermatology and Skin Cancer Institute - Beverly Hills — Sherman Oaks, California

Advanced Dermatology and Skin Cancer Institute - Beverly Hills is a clinical research site located in Sherman Oaks, California, United States 91403.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Advanced Dermatology and Skin Cancer Institute - Beverly Hills has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Plaque Psoriasis.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sherman Oaks

Browse all research sites in California · View every site in Sherman Oaks

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Advanced Dermatology and Skin Cancer Institute - Beverly Hills?

Advanced Dermatology and Skin Cancer Institute - Beverly Hills has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Advanced Dermatology and Skin Cancer Institute - Beverly Hills conducted?

Advanced Dermatology and Skin Cancer Institute - Beverly Hills has 1 clinical trials on record, with 1 currently active. Their work covers Plaque Psoriasis.

Is Advanced Dermatology and Skin Cancer Institute - Beverly Hills accredited by Crixeo Clinical Trials?

Advanced Dermatology and Skin Cancer Institute - Beverly Hills has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Advanced Dermatology and Skin Cancer Institute - Beverly Hills?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.